论文部分内容阅读
目的:分析阿奇霉素治疗支气管哮喘疗效,并对其用药安全性进行观察。方法:选取2015年7月-2016年10月91例支气管哮喘患者,随机分组,对照组采用常规疗法,观察组在此基础上采用阿奇霉素辅助治疗,比较2组患者临床治疗效果。结果:2组均未出现明显用药不良反应现象,观察组临床治疗总有效率为93.3%,对照组为80.4%,组间差异明显(P<0.05);观察组肺哮鸣音消失时间、咳嗽消失时间、呼吸困难改善时间均低于对照组(P<0.05)。结论:阿奇霉素辅助疗法治疗效果明显,可改善临床症状,提高治疗效果,具有用药安全性。
Objective: To analyze the curative effect of azithromycin on bronchial asthma and to observe the safety of its medication. Methods: Ninety-one patients with bronchial asthma from July 2015 to October 2016 were selected and randomly divided into two groups. The control group was treated with conventional therapy. The observation group was treated with azithromycin on the basis of this treatment. The clinical effect of the two groups was compared. Results: There was no significant adverse drug reaction in both groups. The total effective rate was 93.3% in the observation group and 80.4% in the control group, with significant difference between the two groups (P <0.05) Disappear time, dyspnea time were lower than the control group (P <0.05). Conclusion: Azithromycin adjuvant therapy has obvious therapeutic effect, which can improve clinical symptoms, improve the therapeutic effect and have the safety of medication.